Shanghai Argo Biopharmaceutical Co., Ltd.

This early-phase trial will test the safety and tolerability of a single injection of BW-41012 in 40 healthy adults aged 18 to 65. Participants will be randomly assigned to receive either the drug or a placebo, and researchers will monitor for side effects and measure how the dru…

This early-phase trial is testing the safety and tolerability of a new drug called BW-50218 in 60 healthy adults. Participants receive a single injection of either the drug or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is…